SEC Form 4: Valliant John sold $10,459 worth of shares (1,500 units at $6.97) as part of a pre-agreed trading plan, decreasing direct ownership by 0.39% to 385,964 units

ByQuantisnow·Wall Street's wire, on your screen.

FUSN· Fusion Pharmaceuticals Inc.

Health Care

Original source

SEC Form 4: Valliant John sold $10,459 worth of shares (1,500 units at $6.97) as part of a pre-agreed trading plan, decreasing direct ownership by 0.39% to 385,964 units | Quantisnow